ws

West Pharmaceutical Services

WST
NYSE
$240.13

West Pharmaceutical Services a-t-elle un rempart concurrentiel (moat) solide ?

West Pharmaceutical Services operates with a narrow competitive moat. While the business generates acceptable returns, it lacks the consistent margin superiority or return on capital that would indicate strong pricing power or durable competitive advantages. Competition could erode profitability over time.